Sens. Amy Klobuchar, D-Minn., Susan Collins, R-Maine, Jacky Rosen, D-Nev., and Chuck Grassley, R-Iowa, yesterday introduced AHA-supported legislation (S. 948) to improve and extend the Conrad State 30 program until 2021. First enacted in 1994, the program allows state health departments to request J-1 visa waivers for up to 30 foreign physicians per year to work in federally designated Health Professions Shortage Areas or Medically Underserved Areas. The Conrad State 30 and Physician Access Act would increase the state allocations to 35 physicians per year and provide flexibility to further expand the number of waivers in states where the demand exceeds the limit, among other improvements. “The latest extension of the Conrad State 30 Program will expire later this year, which is why we urge action to extend this critical program,” AHA said. “Without timely reauthorization, patient access to care in the many communities that have benefited from these physicians may be threatened. We also support the program improvements contained in the Conrad State 30 and Physician Access Act as part of this extension and stand ready to work with you and your colleagues to move this legislation forward.”

Perspective
Public
Two days from now, the AHA will welcome more than 1,000 health care leaders to our 2026 Annual Membership Meeting in Washington, D.C.This yearly gathering…
Headline
Americans across 43 states enrolled in health plans from the nation’s four largest commercial health insurers face potential disparities in finding in-network…
Headline
Secretary of Health and Human Services Robert F. Kennedy Jr. April 16 testified during two House hearings on the HHS fiscal year 2027 budget proposal, which…
Headline
The Centers for Medicare & Medicaid Services April 10 released a proposed rule that would establish electronic standards for drug prior authorizations.…
Perspective
Public
Few patient populations are more vulnerable to the shifting winds around health care today than Medicare beneficiaries who need specialized, high-acuity and…
Headline
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin…